Cargando…
Synthesis and Antitumor Evaluation of Novel Bis-Triaziquone Derivatives
Aziridine-containing compounds have been of interest as anticancer agents since late 1970s. The design, synthesis and study of triaziquone (TZQ) analogues with the aim of obtaining compounds with enhanced efficacy and reduced toxicity are an ongoing research effort in our group. A series of bis-type...
Autores principales: | Huang, Cheng Hua, Kuo, Hsien-Shou, Liu, Jia-Wen, Lin, Yuh-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255275/ https://www.ncbi.nlm.nih.gov/pubmed/19633605 http://dx.doi.org/10.3390/molecules14072306 |
Ejemplares similares
-
Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives
por: Wan, Qi, et al.
Publicado: (2019) -
Design, Synthesis, and Biological Evaluation of Novel Biotinylated Podophyllotoxin Derivatives as Potential Antitumor Agents
por: Zi, Cheng-Ting, et al.
Publicado: (2019) -
The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone
por: Yang, Yu-Ping, et al.
Publicado: (2005) -
Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents
por: An, Ran, et al.
Publicado: (2018) -
First synthesis of novel 2,4-bis((E)-styryl)quinoline-3-carboxylate derivatives and their antitumor activity
por: Gao, Wentao, et al.
Publicado: (2018)